Abbott Laboratories
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ABT.MX | ABBOTINDIA.NS | LLY | JNJ | BMY | INDSWFTLAB.NS | |
|---|---|---|---|---|---|---|
| Market cap | 3.73T | 565.34B | 1.26T | 665.19B | 131.21B | 31.52B |
| P/E (TTM) | 45.4 | 35.0 | 46.0 | 41.9 | 14.2 | 37.0 |
| Forward P/E | — | 29.4 | 28.3 | 23.8 | 9.6 | — |
| Price/book | 3.9 | 11.8 | 31.4 | 8.2 | 5.6 | 2.1 |
| Dividend yield | 2.20% | 1.94% | 0.49% | 1.94% | 3.93% | — |
| 1-year change | −6.86% | −7.93% | +51.26% | +47.79% | +37.66% | +240.08% |
| Today | +4.60% | −1.90% | +0.61% | +3.81% | +4.02% | −3.72% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All ABT.MX news ›Abbott Laboratories Stock (ABT) Moved Up by 3.67% on Nov 2: A Full Analysis
TradingKey Abbott Laboratories Stock (ABT) Moved Up by 3.67% on Nov 2: A Full Analysis What is driving Abbott Laboratories (ABT)’s stock price up today? Positive clinical data presentations at the Transcatheter Cardiovascul
Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche Diagnostics, and QuidelOrtho in the Point-of-Care Molecular Diagnostics Market as It Reaches USD 15.1 Billion by 2036, Growing at 10.0% CAGR
Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche openPR.com Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche Diagnostics, and QuidelOrtho in the Point-of-Care Molecular Diagnostics Market as It Reaches USD 15.1…
The Market for Congestive Heart Failure Treatment Devices Is Projected to Grow to $30.07 Billion by 2030
The market for congestive heart failure treatment devices is witnessing substantial advancement driven by ongoing innovations and expanding demand As cardiovascular diseases continue to affect a growing portion of the population the need…
Abbott Laboratories $ABT Stock Acquired by Hollow Brook Wealth Management LLC
Posted by Kim Johansen on Nov 2nd, 2026 The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Thursday, October 15th will be paid a $0.63 dividend. The ex-dividend date is…
Abbott To Spin Off $8.5B Nutrition Business Into Standalone Public Company - EDairy News English
Abbott plans to spin off its $8.5B nutrition business into an independent public company by late 2027, housing Similac, Ensure, and PediaSure. Corporate separation by end of 2027 will create an independent nutrition powerhouse housing…
Abbott to Split Off Nutrition Biz, Q3 Sales Rise 14.5%
Medical Product Outsourcing offers a centralized destination where users can watch expert-led sessions anytime, anywhere The planned spinoff comes as Abbott reports $13 billion in third-quarter sales and narrows its 2026 earnings outlook.…
Abbott Laboratories to Pay $384 Million Over Infant Formula Contamination Risk Claims
Abbott Laboratories has agreed to pay more than $384 million to settle allegations that it manufactured infant formula under conditions that posed a risk of contamination and then sold the products to federal and state programs, the U.S.…
Abbott Laboratories Starts Trial for Device to Treat Mitral Heart Valve Disease
Abbott Laboratories said Thursday it has started a trial assessing the safety and effectiveness of its investigational Cephea mitral valve system to treat people with mitral valve disease who are... Medical Equipment, Supplies &…
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT) and Taysha Gene Therapies (TSHA) with bullish sentiments. TD Cowen analyst Josh Jennings…
Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)
In a report released today, Christopher Pasquale from Barclays maintained a Buy rating on Abbott Laboratories, with a price target of $120.00. According to TipRanks, Pasquale is a 4-star analyst with an average return of 9.7% and a 59.56%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com26
- theglobeandmail.com16
- themarketsdaily.com11
- defenseworld.net7
- seekingalpha.com7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.